Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01YIO
|
||||
| Former ID |
DNC007167
|
||||
| Drug Name |
JNJ-10311795
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Asthma; Chronic obstructive pulmonary disease [ICD9: 490-492, 493, 494-496; ICD10:J40-J44, J47, J45] | Phase 2 | [541688] | ||
| Formula |
C40H35N2O6P
|
||||
| InChI |
InChI=1S/C40H35N2O6P/c1-41(32-19-21-42(22-20-32)39(44)31-18-17-26-9-2-3-11-28(26)23-31)40(45)36-25-30-13-5-4-12-29(30)24-35(36)37(43)38(49(46,47)48)34-16-8-14-27-10-6-7-15-33(27)34/h2-18,23-25,32,38H,19-22H2,1H3,(H2,46,47,48)
|
||||
| InChIKey |
XUJQPDQURBZEGJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Chymase | Target Info | Inhibitor | [528733] | |
| Cathepsin G | Target Info | Inhibitor | [528733] | ||
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
| Reactome | Activation of Matrix Metalloproteinases | ||||
| Metabolism of Angiotensinogen to AngiotensinsR-HSA-1474228:Degradation of the extracellular matrix | |||||
| Metabolism of Angiotensinogen to Angiotensins | |||||
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.